Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill
In This Article:
Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.